Company handles distribution of 'niche' blood, chemotherapy and specialty products
BDI Pharma (Columbia, SC) is in the final stages of construction and licensing of a DC near the Dallas-Fort Worth airport, the better to serve its customers of immunoglobulin, albumin, vaccines, chemotherapy products and other specialty pharmaceuticals. The facility, the company’s second national DC, more than doubles its warehousing capacity and ultimately will manage 40% of its shipments, according to a company statement. There is also room for future expansion.
BDI Pharma provides basic wholesaling services as well as sales and marketing services for manufacturers and reimbursement services for patients, seeking to act as a commercialization extension of its biopharma suppliers.
Earlier this year, it expanded its cold-chain storage capacity and built new offices near its Columbia, SC headquarters; at that time it announced a 40% increase in sales over the previous year.
Protecting Temperature-Sensitive Pharmaceuticals, Without Unnecessary Plastic Waste
March 24th 2025Advances in the life sciences are driving a significant increase in the number of temperature-sensitive pharmaceuticals. The packaging industry is meeting the moment with advances of its own, including high-performance, environmentally-friendly materials that allow life science companies meet stringent thermal requirements and ambitious CO2e reduction goals. In this episode, TemperPack’s CEO Peter Wells shares insights from working with life sciences to move to certified biobased, home compostable, and curbside recyclable shipping solutions.